TY - JOUR
KW - buprenorphine
KW - Extended-release
KW - opioid use disorder
KW - Depot injection
KW - criminal justice involvement
KW - Clinical Trial
KW - Empirical Study
KW - Interview
KW - Qualitative Study
KW - Human
KW - Male
KW - Female
KW - Adulthood (18 yrs & older)
KW - Thirties (30-39 yrs)
KW - Middle Age (40-64 yrs)
KW - COVID-19
KW - Health Care Delivery
KW - Drug Therapy
KW - Client Attitudes
KW - Opiates
KW - Life Experiences
KW - Substance use treatment
KW - article
KW - US
KW - 3386:Criminal Rehabilitation & Penology
KW - 3233:Substance Abuse & Addiction
AU - Anna Cheng
AU - Ryan Badolato
AU - Andrew Segoshi
AU - Ryan McDonald
AU - Mia Malone
AU - Kumar Vasudevan
AU - Beita Badiei
AU - Allison Sugarman
AU - Ross MacDonald
AU - Jasdeep Mangat
AU - Jonathan Giftos
AU - Joshua D. Lee
AU - Babak Tofighi
A1 - 
AD - Department of Population Health, New York University School of Medicine, New York, NY, US babak.tofighi@nyulangone.org; New York City Health + Hospitals, Correctional Health Services, New York, NY, US ; Albert Einstein College of Medicine, New York, NY, US ; Tofighi, Babak,babak.tofighi@nyulangone.org
BT - Addiction Science & Clinical Practice
C5 - Healthcare Disparities; Opioids & Substance Use
DO - 10.1186/s13722-022-00288-4
JF - Addiction Science & Clinical Practice
LA - English
M1 - Journal Article
PY - 2022
SN - 1940-0632, 1940-0632
SP - 9
T1 - Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: An in-depth qualitative study
T2 - Addiction Science & Clinical Practice
TI - Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: An in-depth qualitative study
U1 - Healthcare Disparities; Opioids & Substance Use
U3 - 10.1186/s13722-022-00288-4
VL - 17
VO - 1940-0632, 1940-0632
Y1 - 2022
Y2 - Jan 29
ER -